Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release.
Martinotti G, Barlati S, Prestia D, Palumbo C, Giordani M, Cuomo A, Miuli A, Paladini C, Amore M, Bondi E, Vita A, Fagiolini A, Di Giannantonio M. Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release. Psychopharmacology (Berl). 2020 11; 237(11):3497-3501.